Clinical Trial Update: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating guselkumab for moderately to severely active Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn's Disease | Phase 3 | Status: RECRUITING